Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care

Recruiting now · Phase 4

Conditions studied: Human Immunodeficiency Virus (HIV), Smoking Cessation

In brief

This study's long-term goal is to improve clinical outcomes among smokers living with HIV (SLWH) by providing smoking cessation interventions in HIV clinical care that will increase the chances of quitting smoking, limits costs and burden on staff and reach many smokers living with HIV.

Key facts

Study ID

NCT06598397

Run by

New York University

People needed

500

Starts

2024-10-18

Expected to finish

2028-06-30

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Status as HIV+
• Age 18 or older
• Currently smokes ≥ 5 CPD, on average, in past month
• Positive for salivary cotinine
• Able to understand the nature of the study and the consenting process
• Is engaged in HIV clinical care
• Living in larger NYC metropolitan area currently and for the next 6-8 months

You may not qualify if…

• Suffers from any medical condition or contraindication precluding use of nicotine replacement therapy
• Current use of any tobacco cessation medications (varenicline, NRT patch, nicotine gum, lozenge, spray or inhaler, or bupropion)
• Currently participating in a smoking cessation program
• Pregnant or nursing and plans to be in next 6 months
• Has schizophrenia/schizo-affective disorder
• Does not have a functioning mobile phone that can receive text messages

Where it is running

• New York University School of Global Public Health — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.